CDKN2A and melanoma: According to a Swedish study, CDKN2A positive families accounted for 11.5% (31/269) of all melanoma families, and the positivity correlated with the number of affected individuals; in the positive families a median of 6 individuals melanomas were diagnosed compared to 2 individuals in mutation negative families [28].